G1 Therapeutics Inc.
G1 Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and delivery of innovative therapies for those affected by cancer.
Employment range in NC
Primary site activity
All company activities
Products on market
Trilaciclib (Cosela), a myeloprotection therapy for decreasing incidence of chemotherapy-induced myelosuppression
Products under development
lerociclib (CDK4/6 inhibitor); G1T48 (oral SERD)